Literature DB >> 18775427

The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand.

Hidetaka Hayashi1, Ken-ichi Nakahama, Takahiro Sato, Takehiko Tuchiya, Yasuyuki Asakawa, Toshimitu Maemura, Masanobu Tanaka, Mineto Morita, Ikuo Morita.   

Abstract

Multinuclear osteoclasts are derived from CD11b-positive mononuclear cells in bone marrow and in circulation. FACS sorting experiments showed impaired osteoclastogenesis in RAW264.7 cells with low CD11b expression. Neutralizing antibodies and siRNA against CD11b inhibited osteoclastogenesis induced by RANKL. Although primary cultured mouse bone marrow macrophages expressed CD11a and CD11b, osteoclastogenesis induced by M-CSF and RANKL was inhibited in the presence of anti-CD11b or anti-CD18 but not anti-CD11a antibodies. Furthermore, anti-CD11b antibodies inhibited NFATc1 expression induced by M-CSF and RANKL in BMMs. These findings suggest, at least partly, an important role of CD11b in osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775427     DOI: 10.1016/j.febslet.2008.08.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

Review 2.  Titanium oral implants: surface characteristics, interface biology and clinical outcome.

Authors:  Anders Palmquist; Omar M Omar; Marco Esposito; Jukka Lausmaa; Peter Thomsen
Journal:  J R Soc Interface       Date:  2010-06-30       Impact factor: 4.118

3.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

4.  Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration.

Authors:  Omar Omar; Maria Lennerås; Sara Svensson; Felicia Suska; Lena Emanuelsson; Jan Hall; Ulf Nannmark; Peter Thomsen
Journal:  J Mater Sci Mater Med       Date:  2009-10-25       Impact factor: 3.896

5.  Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2.

Authors:  Michael S Valerio; Bethany A Herbert; Dimitrios S Basilakos; Courtney Browne; Hong Yu; Keith L Kirkwood
Journal:  Cytokine       Date:  2014-09-27       Impact factor: 3.861

Review 6.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

7.  Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Authors:  Alexandru Movila; Takenobu Ishii; Abdullah Albassam; Wichaya Wisitrasameewong; Mohammed Howait; Tsuguno Yamaguchi; Montserrat Ruiz-Torruella; Laila Bahammam; Kazuaki Nishimura; Thomas Van Dyke; Toshihisa Kawai
Journal:  J Bone Miner Res       Date:  2016-06-02       Impact factor: 6.741

8.  Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.

Authors:  Toral D Zaveri; Natalia V Dolgova; Jamal S Lewis; Kiri Hamaker; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Biomaterials       Date:  2016-10-27       Impact factor: 12.479

9.  MKP-1 is essential for canonical vitamin D-induced signaling through nuclear import and regulates RANKL expression and function.

Authors:  Alfred C Griffin; Michael J Kern; Keith L Kirkwood
Journal:  Mol Endocrinol       Date:  2012-08-16

10.  Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts.

Authors:  Kosuke Mizutani; Sudha Sud; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.